全文获取类型
收费全文 | 3959篇 |
免费 | 336篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 134篇 |
妇产科学 | 67篇 |
基础医学 | 615篇 |
口腔科学 | 57篇 |
临床医学 | 415篇 |
内科学 | 633篇 |
皮肤病学 | 78篇 |
神经病学 | 467篇 |
特种医学 | 230篇 |
外科学 | 591篇 |
综合类 | 58篇 |
一般理论 | 3篇 |
预防医学 | 336篇 |
眼科学 | 117篇 |
药学 | 234篇 |
中国医学 | 6篇 |
肿瘤学 | 200篇 |
出版年
2021年 | 62篇 |
2020年 | 43篇 |
2019年 | 68篇 |
2018年 | 84篇 |
2017年 | 44篇 |
2016年 | 58篇 |
2015年 | 76篇 |
2014年 | 94篇 |
2013年 | 173篇 |
2012年 | 187篇 |
2011年 | 228篇 |
2010年 | 122篇 |
2009年 | 102篇 |
2008年 | 175篇 |
2007年 | 186篇 |
2006年 | 195篇 |
2005年 | 196篇 |
2004年 | 201篇 |
2003年 | 166篇 |
2002年 | 167篇 |
2001年 | 100篇 |
2000年 | 79篇 |
1999年 | 93篇 |
1998年 | 42篇 |
1997年 | 44篇 |
1996年 | 53篇 |
1995年 | 41篇 |
1994年 | 43篇 |
1993年 | 34篇 |
1992年 | 62篇 |
1991年 | 62篇 |
1990年 | 58篇 |
1989年 | 49篇 |
1988年 | 71篇 |
1987年 | 53篇 |
1986年 | 55篇 |
1985年 | 47篇 |
1984年 | 39篇 |
1983年 | 27篇 |
1982年 | 32篇 |
1981年 | 22篇 |
1980年 | 29篇 |
1979年 | 49篇 |
1978年 | 34篇 |
1975年 | 34篇 |
1973年 | 28篇 |
1972年 | 26篇 |
1969年 | 21篇 |
1967年 | 24篇 |
1966年 | 20篇 |
排序方式: 共有4304条查询结果,搜索用时 15 毫秒
1.
Knox Joseph A. Kumar Vishal Conrad Miles B. Nanavati Sujal Moore Teri Wilson Mark 《Emergency radiology》2022,29(3):605-609
Emergency Radiology - Access to multi-detector computed tomography (MDCT) scanning for interventional procedures can prove to be logistically challenging as resources are often in different areas... 相似文献
2.
3.
The test–retest reliability of the Incontinence Questionnaire‐Urinary Incontinence Short Form (ICIQ‐UI SF) for assessing type of urinary incontinence in males and females 下载免费PDF全文
Edmond PH Choi RN MPhil BNurs Cindy LK Lam MD MBBS FHKAM Weng Yee Chin MBBS FRACGP 《Journal of clinical nursing》2015,24(23-24):3742-3744
4.
C. Jacquet F. Goehringer E. Baux J.A. Conrad M.O. Ganne Devonec J.L. Schmutz G. Mathey H. Tronel T. Moulinet I. Chary-Valckenaere T. May C. Rabaud 《Médecine et maladies infectieuses》2019,49(2):112-120
Objective
The teaching hospital of Nancy, France, implemented a specific multidisciplinary care pathway (French acronym AMDPL) to improve the management of patients presenting with Lyme borreliosis (LB) suspicion. We aimed to assess the first year of activity of this care pathway.Patients and methods
We included all patients managed in the AMDPL pathway from November 1, 2016 to October 31, 2017. The first step was a dedicated Lyme disease consultation with an infectious disease specialist. Following this consultation, the LB diagnosis was either confirmed and adequate treatment was prescribed, or a differential diagnosis was established and patients received adequate management, or further investigations were required and patients were offered multidisciplinary management as part of a day hospitalization.Results
A total of 468 patients were included. LB diagnosis was confirmed in 15% of patients (69/468), 49% of patients received a differential diagnosis, and 26% (122/468) of patients had the LB diagnosis ruled out without receiving any other diagnosis.Conclusions
This is to our knowledge the first multidisciplinary center implemented in France for the management of patients presenting with LB suspicion related to polymorphous signs and symptoms. Several diagnoses could be confirmed or corrected, although some symptoms and complaints could not be explained. This cohort could improve our knowledge of LB and its differential diagnoses. 相似文献5.
6.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献7.
8.
Nittaya Phanuphak Nipat Teeratakulpisarn Frits van Griensven Nitiya Chomchey Suteeraporn Pinyakorn James LK Fletcher Rapee Trichavaroj Supanit Pattanachaiwit Nelson Michael Praphan Phanuphak Jerome H Kim Jintanat Ananworanich 《Journal of the International AIDS Society》2015,18(1)
Introduction
HIV transmission risk is highest during acute HIV infection (AHI). We evaluated HIV RNA in the anogenital compartment in men who have sex with men (MSM) during AHI and compared time to undetectable HIV RNA after three-drug versus five-drug antiretroviral therapy (ART) to understand risk for onward HIV transmission.Methods
MSM with AHI (n=54) had blood, seminal plasma and anal lavage collected for HIV RNA at baseline, days 3 and 7, and weeks 2, 4, 12 and 24. Data were compared between AHI stages: 1 (fourth-generation antigen-antibody combo immunoassay [IA]–, third-generation IA–, n=15), 2 (fourth-generation IA+, third-generation IA–, n=9) and 3 (fourth-generation IA+, third-generation IA+, western blot–/indeterminate, n=30) by randomization to five-drug (tenofovir+emtricitabine+efavirenz+raltegravir+maraviroc, n=18) versus three-drug (tenofovir+emtricitabine+efavirenz, n=18) regimens.Results
Mean age was 29 years and mean duration since HIV exposure was 15.4 days. Mean baseline HIV RNA was 5.5 in blood, 3.9 in seminal plasma and 2.6 log10 copies/ml in anal lavage (p<0.001). Blood and seminal plasma HIV RNA were higher in AHI Stage 3 compared to Stage 1 (p<0.01). Median time from ART initiation to HIV RNA <50 copies/ml was 60 days in blood, 15 days in seminal plasma and three days in anal lavage. Compared with the three-drug ART, the five-drug ART had a shorter time to HIV RNA <1500 copies/ml in blood (15 vs. 29 days, p=0.005) and <50 copies/ml in seminal plasma (13 vs. 24 days, p=0.048).Conclusions
Among MSM with AHI, HIV RNA was highest in blood, followed by seminal plasma and anal lavage. ART rapidly reduced HIV RNA in all compartments, with regimen intensified by raltegravir and maraviroc showing faster HIV RNA reductions in blood and seminal plasma. 相似文献9.
10.